Inhaled Sodium Pyruvate
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
University of Minnesota
Overview
Inhaled Sodium Pyruvate is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Inhaled Sodium Pyruvate clinical trials
Explore related
Medical disclaimer. This page summarizes research about Inhaled Sodium Pyruvate for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.